Cancer Cell Membrane‐Coated Nanoparticles for Personalized Therapy in Patient‐Derived Xenograft Models
Lang Rao(National Institutes of Health), Lisen Lin(National Institutes of Health), Lin‐Lin Bu(Wuhan University), Jianxun Ding(Chinese Academy of Sciences), Hongzhang Deng(National Institutes of Health), Weijing Yang(National Institutes of Health), Guang‐Tao Yu(Wuhan University), Andrew Li(Johns Hopkins University), Haihua Xiao(Chinese Academy of Sciences), Minghui Zan(Wuhan University), Wei Liu(Wuhan University), Rui Tian(National Institutes of Health), Zhi‐Jun Sun(Wuhan University), Qian‐Fang Meng(Shenzhen Bay Laboratory)
Cited by 188
Related Papers
Mesenchymal Stem Cells for Regenerative Medicine
|Cells|2019|1.1k
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Polymeric nanostructured materials for biomedical applications
|Progress in Polymer Science|2016|354
Osteoimmunity‐Regulating Biomimetically Hierarchical Scaffold for Augmented Bone Regeneration
|Advanced Materials|2022|343
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278